2
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Thyroid Diseases
1
Parathyroid Diseases
1
Liver Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Cyclophosphamide
391
Carboplatin
344
Gemcitabine
332
pembrolizumab
331
Cisplatin
328
Paclitaxel
298
Radiotherapy
297
Docetaxel
287
Bevacizumab
253
Rituximab
234
Capecitabine
224
Nivolumab
222
Dexamethasone
206
Fluorouracil
190
fludarabine
178
Oxaliplatin
177
Pemetrexed
153
Doxorubicin
153
Irinotecan
148
Leucovorin
144
Etoposide
144
Cytarabine
134
Cetuximab
130
fludarabine phosphate
129
Bortezomib
129
Lenalidomide
126
Filgrastim
120
Erlotinib Hydrochloride
120
Temozolomide
113
Radiosurgery
113
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Hyperspectral Imaging
×
Clear all
NCT04589884
2024-01-09
iEXMachyna3
IHU Strasbourg
Terminated
112 enrolled